Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22034
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Aged,Antibodies, Monoclonal/*administration & dosage/adverse effects/therapeutic use,Antibodies, Monoclonal, Humanized,Antirheumatic Agents/*administration & dosage/adverse effects/therapeutic use,Arthritis, Rheumatoid/*drug therapy/immunology/physiopathology,Blood Sedimentation,C-Reactive Protein/analysis,Drug Administration Schedule,Female,Health Status Indicators,Humans,Joints/physiopathology,Male,Middle Aged,Platelet Count,Treatment Outcome,Tumor Necrosis Factor-alpha/antagonists & inhibitors
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22034
ISSN: 0003-4967
Link: http://www.ncbi.nlm.nih.gov/pubmed/15975964
http://ard.bmj.com/content/65/2/257
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Drosos-2006-efficacy and safety.pdf500.59 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons